Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-20

Clinical Trial Update: S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial results for S1207, comparing hormone therapy with and without everolimus, in breast cancer have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Everolimus (everolimus)
  • S1207

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-12-20